PDI expression is higher in some cancers and involved in aggressive phenotypes of breast cancer [62], brain cancer [63] ovary cancer [64], prostate cancer [65], ovarian cancer [64] and HCC [66]. Here, P4HB is linked to prostate carcinoma.